Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News Unlocking the medicinal secrets of Alexandrian Laurel: A comprehensive insight Alexandrian Laurel, known scientifically as Calophyllum Inophyllum L., reveals a treasure trove of medicinal properties that have been… byPallavi MadhirajuMarch 10, 2024